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Abstract
Introduction:	Magnetic	resonance	imaging	(MRI)	and	electroencephalography	(EEG)	
are a promising means to an objectified assessment of cognitive impairment in 
Alzheimer's	disease	(AD).	Individually,	however,	these	modalities	tend	to	lack	preci‐
sion	in	both	AD	diagnosis	and	AD	staging.	A	joint	MRI–EEG	approach	that	combines	
structural with functional information has the potential to overcome these 
limitations.
Materials and Methods: This cross‐sectional study systematically investigated the 
link	between	MRI	and	EEG	markers	and	the	global	cognitive	status	in	early	AD.	We	
hypothesized	that	the	joint	modalities	would	identify	cognitive	deficits	with	higher	
accuracy	than	the	individual	modalities.	In	a	cohort	of	111	AD	patients,	we	combined	
MRI	measures	of	cortical	thickness	and	regional	brain	volume	with	EEG	measures	of	
rhythmic	 activity,	 information	 processing	 and	 functional	 coupling	 in	 a	 generalized	
multiple regression model. Machine learning classification was used to evaluate the 
markers’ utility in accurately separating the subjects according to their cognitive 
score.
Results:	We	found	that	 joint	measures	of	temporal	volume,	cortical	thickness,	and	
EEG	slowing	were	well	associated	with	the	cognitive	status	and	explained	38.2%	of	
ifs	 variation.	 The	 inclusion	 of	 the	 covariates	 age,	 sex,	 and	 education	 considerably	
improved the model. The joint markers separated the subjects with an accuracy of 
84.7%,	which	was	considerably	higher	than	by	using	individual	modalities.
Conclusions:	 These	 results	 suggest	 that	 including	 joint	MRI–EEG	markers	may	be	
beneficial	 in	the	diagnostic	workup,	thus	allowing	for	adequate	treatment.	Further	
studies	in	larger	populations,	with	a	longitudinal	design	and	validated	against	func‐
tional‐metabolic imaging are warranted to confirm the results.
K E Y W O R D S
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1  | INTRODUC TION
Alzheimer's	disease	(AD)	is	a	fatal	disorder	that	is	associated	with	the	
accumulation of β‐amyloid	 plaques	 and	 neurofibrillary	 tau	 tangles	
causing progressive neurodegeneration in certain cortical and sub‐
cortical	regions	(Hyman	et	al.,	2012).	AD	invariably	affects	episodic	
memory	and	other	complex	cognitive	processes,	but	the	perceived	
onset and early course of the symptoms are highly subjective and 
depend	on	the	 individual	cognitive	reserve	(Stern,	2012).	An	accu‐
rate clinical assessment of the cognitive deficits is crucial for disease 
staging and thus for optimal pharmacological treatment and ther‐
apy	planning.	Typically,	 cognitive	 impairment	 is	 assessed	 in	 a	doc‐
tor–patient/–caregiver	interview	and	neuropsychological	screening	
tests	 such	 as	 the	mini‐mental	 state	 examination	 (MMSE;	 Folstein,	
Folstein,	&	McHugh,	1975).	These	tests,	however,	are	susceptible	to	
daily	variations,	and	their	outcome	is	affected	by	sociodemographic	
factors	and	the	individual	cognitive	reserve	(Crum,	Anthony,	Bassett,	
&	Folstein,	1993).	Consequently,	there	is	a	need	for	accurate	alter‐
natives	to	measure	the	progression	of	cognitive	impairment	in	AD.
Magnetic resonance imaging (MRI) and electroencephalography 
(EEG)	are	potential	surrogate	in	vivo	measures	of	AD	progression	that	
are	noninvasive,	inexpensive,	and	widely	available.	MRI	measures	of	
regional brain volumes and cortical thickness are promising markers 
of	 both	 AD	 neuropathology	 and	 cognitive	 decline	 (Babiloni	 et	al.,	
2015;	Dubois	et	al.,	2014;	Scheltens,	Fox,	Barkhof,	&	De	Carli,	2002).	
Especially,	 the	 limbic	 system	 in	 the	medial	 temporal	 lobe	 has	 been	
identified	to	be	vulnerable	to	AD:	Typically,	the	entorhinal	cortex	 is	
among	 the	 regions	 affected	 in	 the	 earliest	 disease	 stages	 (Killiany	
et	al.,	2002).	The	hippocampal	volume	appears	to	be	a	good	marker	
of	both	disease	onset	and	its	progression	(Bateman	et	al.,	2012;	Den	
Heijer	et	al.,	2010;	Dickerson	et	al.,	2001;	Jack	et	al.,	2010;	Lo	et	al.,	
2011).	Other	affected	brain	 regions	 include	amygdala,	posterior	as‐
sociation	 cortex,	 and	 the	 cholinergic	 basal	 forebrain	 (Bottino	 et	al.,	
2002;	Braak	&	Braak,	1991;	Dubois	et	al.,	2014).	The	cortical	atrophic	
topography is often in line with the clinical phenotype; subjects with 
verbal	memory	impairment,	for	instance,	frequently	exhibit	early	atro‐
phy	in	the	left	temporal	lobe	(Johnson,	Fox,	Sperling,	&	Klunk,	2012).
Electroencephalography,	on	the	other	hand,	is	a	promising	tool	to	
assess	the	AD‐related	functional	disintegration	of	large	scale	brain	
networks such as the default mode network during resting state 
(Dillen	et	al.,	 2017;	Horn,	Ostwald,	Reisert,	&	Blankenburg,	2014).	
Visual	resting	state	EEG	analyses	in	AD	patients	have	revealed	a	slow	
dominant posterior rhythm and an increase in widespread delta and 
theta	activity	combined	with	a	reduction	in	alpha	and	beta	(Berger,	
1937;	 Brenner,	 Reynolds,	 &	 Ulrich,	 1988;	 Gordon	 &	 Sim,	 1967;	
Letemendia	 &	 Pampiglione,	 1958;	 Liddell,	 1958;	 Rae‐Grant	 et	al.,	
1987;	 Soininen,	 Partanen,	 Helkala,	 &	 Riekkinen,	 1982;	 Weiner	 &	
Schuster,	1956).	These	abnormal	EEG	patterns	have	shown	correla‐
tions	with	the	cognitive	status	as	well	(Brenner	et	al.,	1988;	Gordon	
&	Sim,	1967;	Johannsen,	Jakobsen,	Bruhn,	&	Gjedde,	1999;	Kaszniak,	
Garron,	Fox,	Bergen,	&	Huckman,	1979;	Liddell,	1958;	Merskey	et	al.,	
1980;	Mundy‐Castle,	Hurst,	Beerstecher,	&	Prinsloo,	1954;	Obrist,	
Busse,	Eisdorfer,	&	Kleemeier,	1962;	Rae‐Grant	et	al.,	1987;	Roberts,	
McGeorge,	&	Caird,	1978;	Weiner	&	Schuster,	1956).	Computerized	
resting	state	EEG	studies	have	confirmed	these	early	studies;	they	
used	the	spectral	power	in	predefined	frequency	bands	to	quantify	
EEG	rhythmicity,	synchrony‐measures	such	as	coherence	to	quantify	
EEG	connectivity,	and	measures	from	information	theory	to	quantify	
EEG	complexity	(see	Jeong,	2004	and	Dauwels,	Vialatte,	&	Cichocki,	
2010	 for	extensive	 reviews).	Besides	 resting	 state	analyses,	grow‐
ing	 evidence	 suggests	 that	 the	 EEG	 recorded	 during	memory	 en‐
coding	tasks	carries	essential	information	about	other	AD‐affected	
large‐scale	brain	networks	(Garn	et	al.,	2014,	2015;	Hidasi,	Czigler,	
Salacz,	Csibri,	&	Molnár,	2007;	Hogan,	Swanwick,	Kaiser,	Rowan,	&	
Lawlor,	2003;	Jiang,	2005;	Jiang	&	Zheng,	2006;	Klimesch,	Sauseng,	
&	Hanslmayr,	2007;	Pijnenburg	et	al.,	2004;	Stam,	2000;	Stam,	van	
Cappellen	van	Walsum,	&	Micheloyannis,	2002;	Van	der	Hiele	et	al.,	
2007;	Waser	et	al.,	2016).	With	this	in	mind,	EEG	measures	such	as	
upper	 alpha	 desynchronization	 and	 theta	 synchronization	 during	
memory encoding might be the potential markers of impaired mem‐
ory	performance	(Klimesch,	1999).
Despite	their	evident	potential	as	noninvasive	assistive	tools	in	AD	
diagnose,	MRI	 is	 routinely	 used	 solely	 for	 the	 purpose	 of	 excluding	
other	possible	causes	such	as	vascular	lesions,	strategic	lunar	infarcts,	
or	cerebral	haemorrhages	(Dubois	et	al.,	2014;	Schmidt	et	al.,	2010),	and	
EEG	is	not	included	in	the	standard	diagnostic	workup	at	all	(American	
Psychiatric	Association,	2013;	Dubois	et	al.,	2007,	2010,	2014;	Hyman	
et	al.,	2012;	McKhann	et	al.,	1984,	2011;	Schmidt	et	al.,	2010).	A	rea‐
son	is	that,	individually,	these	modalities	tend	to	lack	precision	in	both	
AD	diagnosis	and	staging.	However,	combining	the	structural	and	func‐
tional	information	from	MRI	and	EEG	in	a	multimodal	approach	has	the	
potential to overcome the limitations of the individual modalities. This 
cross‐sectional study systematically investigates the usefulness of dif‐
ferent	MRI	and	EEG	measures	as	symptom‐independent	markers	of	the	
cognitive	deficits	in	a	cohort	of	early	AD	patients.	We	hypothesize	that	
(a) these markers are significantly related to global cognition as mea‐
sured	by	MMSE	in	early	AD	and	that	(b)	joint	MRI–EEG	markers	allow	
for an accurate identification of significant cognitive deficits.
2  | MATERIAL S AND METHODS
2.1 | Ethics statement
This research was approved by the ethics committees of the Medical 
Universities	Graz,	 Innsbruck,	Vienna	 and	 the	Ethics	Committee	of	
the	State	of	Upper	Austria.
2.2 | Study cohort
The study cohort consisted of 111 subjects diagnosed with probable 
(N = 77) or possible (N	=	34)	AD	according	to	NINCDS‐ADRDA1 criteria 
(McKhann	et	al.,	1984)	who	participated	in	the	prospective	dementia	
(PRODEM)	study	of	the	Austrian	Alzheimer	Society	(Seiler	et	al.,	2012).	
1National	 Institute	 of	 Neurological	 and	 Communicative	 Disorders	 and	 Stroke	 and	
Alzheimer's	Disease	and	Related	Disorders	Association.	
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Enrollment	criteria	 included	the	availability	of	a	caregiver,	written	in‐
formed	consent	of	participant	and	caregiver,	no	need	for	24‐hr	care,	
and the absence of other physical or neurological causes of dementia‐
like	 symptoms.	 All	 patients	 underwent	 a	 routine	 laboratory	 assess‐
ment,	measurement	of	serum	vitamin	B12	and	folic	acid	levels,	as	well	
as	serologic	(HIV,	Lues)	and	thyroid	testing.	AD‐inconsistent	patterns	of	
cerebral	 atrophy	 and	 lesion	were	 excluded	 in	 T1‐weighted	MRI	 (3D	
MPRAGE)	sequences.	The	dementia	severity	was	assessed	by	clinical	
dementia rating (CDR) on a scale of 0 (no dementia) to 3 (severe demen‐
tia)	(Hughes,	Berg,	Danziger,	Coben,	&	Martin,	1982;	Morris,	1993).	Our	
cohort consisted of subjects with CDR scores of 0.5 (very mild demen‐
tia) or 1 (mild dementia). The global cognition was assessed by MMSE 
scores	on	a	scale	of	0–30	where	scores	below	24	indicate	significant	
cognitive	deficits	(Folstein	et	al.,	1975;	Mungas,	1991).	The	participants’	
age,	sex,	and	completed	years	of	education	were	included	as	potential	
confounders	(Crum	et	al.,	1993;	Kittner	et	al.,	1986;	O'Connor,	Pollitt,	
Treasure,	Brook,	&	Reiss,	1989).
2.3 | MRI assessment
The brain structure was assessed by T1‐weighted whole‐brain MRI 
scanning	(3D	MPRAGE	sequence)	on	one	of	the	three	different	sys‐
tems	(Avanto	1.5	T,	Symphony	Tim	1.5	T	and	Trio	Tim	3.0	T,	all	were	
manufactured	 by	 Siemens	 Healthcare,	 Erlangen,	 Germany).	 The	
selected	sequence	parameters	were	echo	time	3.0	ms	(1.9–4.2	ms),	
repetition	time	2,020	ms	(1,410–2,300	ms),	inversion	time	1,017	ms	
(800–1,100	ms),	 flip	 angle	 9°,	 10°	 and	 15°,	 resolution	 0.9	mm	
(0.83–1	mm)	×	0.9	mm	 (0.83–1	mm)	×	1	mm	 (1–1.2	mm),	 and	 band‐
width	130	Hz.
MRI	 scans	 were	 processed	 with	 the	 FreeSurfer	 neuroimaging	
software	 (Version	 5.3,	 Massachusetts	 General	 Hospital,	 Boston	
MA,	USA)	that	included	automated	methods	for	volume	segmenta‐
tion and measurement of cortical thickness of various brain regions. 
Briefly,	the	processing	flow	consisted	of	skull	stripping	followed	by	
segmentation of gray/white matter and mapping of different brain 
structures	 in	 Talairach	 space	 (Desikan	 et	al.,	 2006;	 Fischl	 et	al.,	
2002).	A	detailed	technical	description	can	be	found,	for	example,	in	
Fischl	et	al.,	2002	and	Reuter,	Schmansky,	Rosas,	&	Fischl,	2012.	In	
previous	studies,	these	morphometric	FreeSurfer	procedures	were	
validated	 against	 manual	 mapping	 (Fischl	 et	al.,	 2002;	 Kuperberg	
et	al.,	2003;	Salat	et	al.,	2004)	and	proved	to	be	reliable	across	scan‐
ner	types	and	field	strengths	(Han	et	al.,	2006;	Reuter	et	al.,	2012).
The	regional	volume	and	mean	cortical	 thickness	of	 the	 frontal,	
parietal,	 left	 and	 right	 temporal,	 and	 occipital	 lobe	 of	 the	 cerebral	
cortex	–	the	major	control	of	higher	cognitive	 function	–	were	em‐
ployed as potential markers of cognitive impairment. The left and right 
temporal lobes were hereby assessed separately since the left tem‐
poral	lobe	has	been	described	to	be	more	affected	in	early	AD	stages	
(Johnson	et	al.,	2012).	In	addition,	we	included	the	volume	of	entorhi‐
nal	cortex,	hippocampus,	and	amygdala	due	to	their	vulnerability	to	
atrophy	in	early	AD	(Juottonen,	Laakso,	Partanen,	&	Soininen,	1999;	
Poulin,	Dautoff,	Morris,	Barrett,	&	Dickerson,	2011).	All	MRI	measures	
were	normalized	by	the	individual	total	intracranial	volume	to	account	
for	anatomical	differences	between	the	subjects	(Fischl,	2012).
2.4 | EEG assessment
The	brain	function	was	assessed	by	EEG	recordings	collected	from	
19	gold	cup	electrodes	(Fp1,	Fp2,	F7,	F3,	Fz,	F4,	F8,	T7,	C3,	Cz,	C4,	
T8,	P7,	P3,	Pz,	P4,	P8,	O1,	and	O2;	ground	between	Fz	and	Cz;	con‐
nected mastoids as reference) placed according to the international 
10–20	system	(Jasper,	1958).	Vertical	and	horizontal	EOG	and	wrist‐
ECG	were	recorded	in	parallel.	All	clinics	used	identical	EEG	systems	
(AlphaEEG	amplifier	by	Alpha	Trace	Medical	Systems,	Vienna,	Austria	
with	NeuroSpeed	software,	bandpass	0.3–70	Hz	(3	dB),	notch	50	Hz,	
sampling	rate	256	Hz,	and	resolution	16	bits).	Impedances	were	kept	
below 10 kOhm.
The	 recordings	were	 conducted	 in	 quiet	 and	 separated	 rooms	
with soft light in accordance with a predefined paradigm. Participants 
sat upright in comfortable chairs with neck support and a monitor 
positioned in front of them. They were asked to reduce movements 
to	a	minimum.	A	recording	session	included	a	30‐s	resting	phase	with	
closed eyes (REC) and a 30‐s memory encoding test with open eyes 
(ENC)	where	on‐screen	face–name	combinations	had	to	be	memo‐
rized.	 This	 test	was	 designed	 to	 capture	AD‐specific	 visual‐verbal	
memory deficits. The details of the paradigm were described else‐
where	(Garn	et	al.,	2015).
TA B L E  1  Summary	of	potential	electroencephalography	(EEG)	
markers
EEG markers Channels Assessment phase
Individual alpha 
frequency
P3,	Pz,	P4,	O1,	O2 Rest,	eyes	closed
Spectral delta‐power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Spectral theta power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Spectral alpha1 power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Spectral alpha2 power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Spectral beta1 power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Spectral beta2 power F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Auto‐mutual	
information
F3,	F4,	C3,	C4,	
O1,	O2
Visual‐verbal	
encoding
Interhemispheric 
coherence
F3‐F4,	C3‐C4,	
O1‐O2
Visual‐verbal	
encoding
Intrahemispheric 
coherence
F3‐C3,	F3‐O1,	
C3‐O1,	F4‐C4,	
F4‐O2,	C4‐O2
Visual‐verbal	
encoding
Interhemispheric 
mutual info
F3‐F4,	C3‐C4,	
O1‐O2
Visual‐verbal	
encoding
Intrahemispheric 
mutual info
F3‐C3,	F3‐O1,	
C3‐O1,	F4‐C4,	
F4‐O2,	C4‐O2
Visual‐verbal	
encoding
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We	 used	 Matlab	 software	 (Version	 R2016b,	 MathWorks,	
Natick	MA,	USA)	to	remove	non‐neuronal	artifacts	from	the	EEG.	
More	specifically,	each	 recording	was	downsampled	 to	128	Hz	 to	
reduce computational cost and bandpass filtered in the range of 
1–30	Hz	 (type	1	FIR	 filter,	60	dB).	Eye	artifacts	were	 removed	by	
constrained	independent	component	analysis	using	the	EOG	(Lu	&	
Rajapakse,	2006).	Cardiac	 artifacts	were	 corrected	by	a	modified	
Pan‐Tompkins	algorithm	using	the	ECG	(Waser	&	Garn,	2013).	The	
resulting	EEG	samples	were	divided	in	2‐s	epochs	with	1‐s	overlap	
(Blanco,	Garcia,	Quiroga,	Romanelli,	&	Rosso,	1995).	Epochs	with	re‐
sidual artifacts were identified by a thresholding algorithm (Waser 
et	al.,	2017),	visually	validated	by	an	EEG	expert	and	omitted	from	
further analyses.
The	EEG	measures	listed	in	Table	1	were	computed	epoch‐	and	
channel‐wise.	Global	markers	were	derived	separately	for	REC	and	
ENC	by	taking	the	average	over	all	channels	and	epochs	(cf.	Table	1).	
A	technical	marker	description	can	be	found	in	Supporting	informa‐
tion	Material	section	A.	In	brief,	the	dominant	posterior	EEG	rhythm	
was	measured	by	the	individual	alpha	frequency	(IAF)	defined	as	the	
mean	frequency‐position	of	the	spectral	center	of	gravity	between	
8	and	13	Hz.	Using	the	IAF	as	anchor	frequency,	the	spectral	power	
was	 computed	 in	 individualized	 frequency	bands	delta	 from	 IAF‐7	
to	IAF‐5	Hz,	theta	from	IAF‐5	to	IAF‐2	Hz,	alpha1	from	IAF‐2	to	IAF	
Hz,	alpha2	from	IAF	to	IAF	+	2	Hz,	beta1	from	IAF	+	2	to	IAF	+	8	Hz	
and	beta2	from	IAF	+	8	to	IAF	+	16	Hz.	The	auto‐mutual	information	
(aMI)	quantified	the	similarity	of	an	EEG	signal	at	different	points	in	
time	and	was	designed	to	capture	EEG	complexity	and	information	
processing	mechanisms	 (Jeong,	Gore,	&	 Peterson,	 2001;	 Shannon	
&	Weaver,	1949).	Inter	and	intrahemispheric	EEG	connectivity	was	
measured by coherence in a linear and by mutual information (cMI) 
in	a	nonlinear	way.	Figure	1	illustrates	the	topographic	logic	of	the	
marker assessment.
2.5 | Statistical analyses
Statistical analyses were performed with the R statistics software 
(Version	 3.4.1,	 R	 Foundation	 for	 Statistical	 Computing,	 Vienna,	
Austria).	We	inspected	the	MMSE	scores,	covariates	(age,	sex,	and	
years	of	education),	as	well	as	MRI	and	EEG	markers	in	histograms,	
scatter‐	and	boxplots.	MMSE	scores	were	log‐transformed	to	make	
them	conform	to	normality.	All	data	were	rescaled	to	z‐scores with 
mean	0	and	standard	deviation	1.	First,	we	tested	the	correlation	of	
MMSE with each individual marker using F‐tests (α	=	0.05).	Second,	a	
generalized	multiple	regression	model	was	used	to	relate	a	combina‐
tion of markers (regressors) to the cognitive scores (outcome) while 
accounting	 for	 age,	 sex,	 and	 education	 (covariates).	More	 specifi‐
cally,	we	used	all‐subset	selection	to	identify	the	marker	subset	that	
described the most MMSE variance in terms of R2 value. To avoid 
overfitting,	models	with	a	large	number	of	regressors	were	hereby	
penalized	using	the	corrected	Akaike	information	criterion	(Akaike,	
1973;	Sugiura,	1978).	The	model	assumptions	were	visually	verified	
in diagnostic residual plots. The regression fit was tested by an over‐
all F‐test and two‐tailed t tests of individual terms (α = 0.05). The 
central statistical concepts are described in detail in Supporting in‐
formation Material Section B.
2.6 | Diagnostic utility assessment
The same marker subset was then used to distinguish subjects with 
MMSE	≥	24	from	those	with	MMSE	<	24	by	a	machine	learning	clas‐
sification approach (see Supporting information Material Section 
B.3).	 We	 used	 a	 support	 vector	 machine	 (SVM)	 with	 radial	 basis	
function	kernel	to	separate	the	two	groups	(Cortes	&	Vapnik,	1995).	
Parameters were hereby tuned using a grid search over defined pa‐
rameter ranges. Classification was performed with leave‐one‐out 
cross‐validation	and	evaluated	by	its	sensitivity	(true	positive	rate),	
specificity	 (true	 negative	 rate),	 and	 accuracy.	 Group	 differences	
regarding	age,	 sex,	and	years	of	education	were	 tested	by	χ²‐ and 
Kruskal–Wallis	tests.
3  | RESULTS
3.1 | Sample characteristics
Table	2	summarizes	the	demographic	and	clinical	sample	character‐
istics. The subjects’ age was negatively correlated with the cogni‐
tive scores (r	=	−0.22,	F(1,109)	=	5.29,	p	=	0.023).	There	was,	however,	
no	significant	age	difference	between	the	subjects	with	MMSE	≥	24	
and	those	with	scores	below	24.	Neither	the	subjects’	sex	nor	their	
completed years of education were significantly related to the 
F I G U R E  1   Electrode placement on the scalp as seen from 
above:	The	dominant	posterior	rhythm	was	measured	in	P3,	Pz,	
P4,	O1,	and	O2	(green	area),	whereas	the	remaining	features	
were	calculated	in	F3,	F4,	C3,	C4,	O1,	and	O2	(blue	dots).	
Interhemispheric couplings are indicated by solid red lines and 
intrahemispheric coupling by dotted red lines
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cognitive	status.	The	 rather	weak	MMSE–CDR	relation	 (휒2
(1)
	=	4.19,	
p	=	0.041)	in	the	earliest	AD	stages	is	in	line	with	previous	findings	
(Perneczky	et	al.,	2006).
3.2 | Neuroimaging markers across the spectrum of 
cognitive impairment
3.2.1 | Individual markers
Table	3	lists	the	MRI	and	EEG	markers	and	their	respective	(non‐nor‐
malized)	mean	values	±	standard	deviation.	In	relating	individual	mark‐
ers	with	MMSE	 scores,	we	 found	 significant	 results	 for	 the	volumes	
of	the	parietal	and	the	left	temporal	lobe,	the	spectral	power	in	theta,	
alpha1,	 beta1,	 and	 beta2,	 as	well	 as	 aMI.	More	 specifically,	 reduced	
lobar	volume,	increased	portions	of	spectral	power	in	a	low	frequency	
range,	and	increased	aMI	were	all	associated	with	lower	MMSE	scores.
Figure	2	 shows	 the	 between‐marker	 correlation	 (Pearson's	 r) 
color‐coded	from	blue	(−1)	to	red	(1)	and	tagged	with	a	(*)	in	case	of	
a high statistical significance (p	<	0.01).	We	observed	a	widespread	
positive correlation between the MRI markers that were most pro‐
nounced in the cortical thickness markers. The relative spectral 
power	 in	the	delta	and	theta	frequency	bands	was	negatively	cor‐
related with the power in the higher beta1 and beta2 bands. The aMI 
showed	 high	 correlations	 with	 beta1	 and	 beta2	 power,	 indicating	
that information processing mechanisms were mainly reflected by 
a	large	portion	of	high‐frequency	EEG	oscillations.	As	for	MRI–EEG	
correlations,	reduced	volume	and	cortical	 thickness	of	the	parietal	
lobe	were	significantly	associated	with	high	delta‐power,	the	parietal	
volume was positively correlated with beta1 power as well as the left 
temporal volume with interhemispheric coherence.
3.2.2 | Marker combinations
The following marker subset was selected to be included in the re‐
gression	model:	the	left	temporal	volume,	the	cortical	thickness	of	
frontal,	parietal	and	occipital	 lobe,	and	the	spectral	power	in	theta	
and alpha2. The regression was significant (p	<	0.001)	and	the	com‐
bined	regressors	explained	38.2%	of	the	variation	in	MMSE	scores.	
Figure	3	 shows	 the	 relation	of	 each	 regressor	 to	 the	MMSE	given	
that the remaining regressors were included in the same model. 
Among	the	 individual	effects,	 theta	power	 (p	<	0.001),	 left	tempo‐
ral volume (p	=	0.007),	 frontal	 thickness	 (p	=	0.001),	 and	 parietal	
thickness (p = 0.003) were significant with the latter two having the 
steepest slopes.
3.3 | Diagnostic utility
Table	4	 summarizes	 the	 results	 of	 discriminating	 the	 two	 groups	
(MMSE	≥	24	and	MMSE	<	24)	using	the	same	marker	subset	from	MRI	
and	EEG	individually,	as	well	as	in	a	modality‐combined	manner.	Using	the	
latter,	individuals	were	classified	with	an	accuracy	of	84.7%	(sensitivity	
92.1%,	specificity	75.0%).	Figure	4	visualizes	the	SVM	results	in	greater	
detail.	The	confusion	matrix	in	Figure	4a	contains	the	true	positive	and	
negative (green) and false positive and negative (red) elements resulting 
from	the	combined	MRI–EEG	classification,	which	correctly	identified	58	
of	63	subjects	with	MMSE	≥	24	and	36	of	48	subjects	with	MMSE	<	24.	
Figure	4b	illustrates	that	the	combined	MRI–EEG	approach	yielded	better	
results as compared to the individual modalities. MRI markers separated 
the	groups	with	an	accuracy	of	only	66.7%	(sensitivity	77.8%,	specific‐
ity	52.1%).	EEG	markers	apparently	reflected	the	cognitive	deficits	bet‐
ter	than	MRI,	and	they	separated	the	groups	with	an	accuracy	of	79.3%	
(sensitivity	87.3%,	specificity	68.8%).
4  | DISCUSSION
The	first	study	question	sought	to	determine	whether	there	was	a	
significant	relation	between	the	MRI–EEG	markers	and	the	severity	
of	cognitive	impairment	in	early	AD.	Prior	studies	have	reported	that	
individual MRI measures of regional volume and cortical thickness 
as	well	as	abnormal	EEG	patterns	are	related	with	the	cognitive	sta‐
tus.	Here,	only	few	individual	markers	were	significantly	correlated	
with	MMSE	scores.	However,	the	combined	MRI–EEG	markers	were	
well associated with the subjects’ cognitive status. By measuring the 
left	temporal	volume,	the	cortical	thickness	of	frontal,	parietal	and	
occipital	 lobe,	and	the	spectral	power	 in	the	theta	and	alpha2	fre‐
quency	bands,	38.2%	of	MMSE	variation	was	explained.	In	line	with	
previous	studies,	the	inclusion	of	age,	sex,	and	education	improved	
these	results	(Crum	et	al.,	1993;	Kittner	et	al.,	1986).	O'Connor	et	al.	
(1989)	 suggested	 that	 also	 the	 sociocultural	 background,	 though	
TA B L E  2   Empirical and statistical sample description
Total
Correlation with MMSE
MMSE ≥ 24 MMSE < 24
Difference
Pearson r p value p value
Subject count 111 63 48
Age	(years) 74.6	±	8.1 −0.22 0.023* 74.8	±	7.2 74.3	±	9.3 0.744
Sex	(female) 61 −0.18 0.065 32 29 0.414
Education (years) 10.9	±	2.9 0.16 0.091 11.2	±	3.2 10.6	±	2.4 0.253
MMSE 23.4	±	3.1 ‐ ‐ 25.5	±	1.4 20.5	±	2.3 ‐
CDR (0.5 | 1) 73 | 38 −0.18 0.055 47	|	16 26	|	22 0.041*
Note. The p	values	in	bold	font	with	an	asterisk	(*)	indicate	statistical	significance	at	alpha	level	0.05.
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difficult	to	quantify,	should	be	included.	Other	potentially	influential	
factors might include medication and lifestyle.
On	the	question	of	the	diagnostic	utility	of	MRI	and	EEG	markers,	
a	 joint	MRI–EEG	 approach	 demonstrated	 higher	 diagnostic	 accuracy	
(84.7%)	 as	 compared	 to	 the	 individual	modalities.	Our	 results	 are	 in	
agreement	 with	 previous	 research,	 showing	 AD	 classification	 accu‐
racies	between	74%–100%	 for	 temporal	 lobe	atrophy	 (O'Brien	et	al.,	
2004),	 76.9%–81.7%	 for	 volumetric	 measures	 of	 medial	 temporal	
structures	(Bottino	et	al.,	2002),	and	87%–99%	for	measures	of	cortical	
volume	and	thickness	(Du	et	al.,	2007).	However,	considering	the	small	
samples	of	these	studies,	the	results	need	to	be	interpreted	with	cau‐
tion.	Similar	results	have	been	found	in	EEG	studies,	with	EEG	markers	
yielding	accuracies	from	76%	to	85%	(Jelic	&	Kowalski,	2009;	Triggiani	
et	al.,	2016).	Thereby,	it	seems	that	the	MRI	and	EEG	modalities	might	
be complementary due to an incomplete overlap in subjects regarding 
MRI	and	EEG	abnormalities	(Strijers	et	al.,	1997).	This	view	got	further	
support	by	a	recent	study	showing	superior	AD‐control	classification	
accuracy	(90%)	for	combined	MRI	and	EEG	markers	as	compared	to	the	
individual	modalities	as	well.	These	data	suggest	that	MRI–EEG	markers	
have potential as accurate cognitive staging tools.
One	interesting	finding	is	that	four	of	the	six	selected	markers	were	
measures	of	cortical	 lobe	atrophy.	Especially,	atrophy	patterns	 in	the	
left	 temporal,	 frontal,	 and	 parietal	 lobe	 are	 in	 accord	 with	 previous	
studies	(Du	et	al.,	2007;	Hwang	et	al.,	2016).	Hartikainen	et	al.	 (2012)	
also	found	occipito–parietal	cortical	thinning	in	AD.	Caution	is	advised;	
however,	for	the	cortical	thickness,	measures	are	highly	inter‐correlated	
and any conclusion on topographic patterns needs further validation. 
In	contrast	to	earlier	findings,	the	medial	temporal	lobe	structures	hip‐
pocampus,	amygdala,	and	entorhinal	cortex	were	not	 included	 in	the	
TA B L E  3   Original magnetic resonance imaging (MRI) and 
electroencephalography	(EEG)	marker	values	(mean	±	standard	
deviation) and linear regression analysis: The slope β refers to the 
linear	regression	coefficient	of	the	normalized	markers	as	
regressors	and	log‐normalized	MMSE	scores	as	outcome,	while	
correcting	for	age,	sex,	and	completed	years	of	education	as	
covariates
Potential markers
Values Regression analysis
Mean ± SD Slope β p value
MRI markers
Cortical volumes [cm³]
Frontal	lobe 122.91	±	17.41 0.053 0.579
Parietal lobe 77.31	±	11.61 0.194 0.037*
Temporal lobe left 38.45	±	6.22 0.188 0.045*
Temporal lobe right 38.48	±	6.13 0.109 0.244
Occipital lobe 35.97	±	5.48 0.126 0.176
Cortical thickness [mm]
Frontal	lobe 2.12	±	0.22 0.137 0.144
Parietal lobe 1.78	±	0.19 −0.009 0.921
Temporal lobe left 2.27	±	0.30 −0.001 0.988
Temporal lobe right 2.34	±	0.33 −0.034 0.721
Occipital lobe 1.60	±	0.12 0.112 0.234
Limbic	volumes	[cm³]
Entorhinal	cortex 2.82	±	0.67 0.080 0.393
Hippocampus 6.28	±	1.19 −0.055 0.564
Amygdala 2.27	±	0.55 0.058 0.543
EEG	markers
Posterior dominant rhythm in rest
Individual alpha 
frequency
9.71	±	0.44 0.093 0.328
Rhythmic activity
Spectral delta power 0.11	±	0.04 −0.176 0.057
Spectral theta power 0.15	±	0.06 −0.380 0.001*
Spectral alpha1 power 0.09	±	0.04 −0.220 0.018*
Spectral alpha2 power 0.07	±	0.02 0.087 0.359
Spectral beta1 power 0.15	±	0.04 0.284 0.002*
Spectral beta2 power 0.17	±	0.07 0.225 0.014*
Information processing
Auto‐mutual	
information
0.31	±	0.01 −0.213 0.021*
Functional	coupling
Interhemispheric 
coherence
0.57	±	0.09 0.177 0.058
Intrahemispheric 
coherence
0.41	±	0.07 0.114 0.223
Interhemispheric 
mutual information
0.19	±	0.01 −0.020 0.834
Intrahemispheric 
mutual information
0.17	±	0.01 −0.037 0.691
Note. The p	values	in	bold	font	with	an	asterisk	(*)	indicate	statistical	signifi‐
cance at alpha level 0.05.
SD: standard deviation. 
F I G U R E  2  Analysis	of	marker	intercorrelation:	The	Pearson's	
correlation	is	shown	color‐coded	and	a	(*)	indicates	a	significant	
intercorrelation	as	tested	by	two‐tailed	Student's	t test (α = 0.01)
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final	model.	A	possible	explanation	might	be	the	strong	innervation	of	
these	structures	and	the	cerebral	cortex	and,	consequently,	 that	 lim‐
bic atrophy was implicitly included through the coarser cortical mea‐
sures.	Another	reason	might	be	that	the	included	EEG	markers	reflected	
the changes in the limbic structures. It also seems possible that these 
relatively small brain structures were subject to measurement bias in 
contrast	to	the	greater	cortical	lobes.	The	most	plausible	explanation,	
however,	is	that	these	brain	structures	have	already	been	affected	long	
before	AD	was	diagnosed	and	that,	during	early	AD,	they	do	not	vary	
as much.
Among	 the	 abnormal	 EEG	 patterns,	 increased	 theta	 and	 de‐
creased	alpha	rhythms,	commonly	referred	to	as	EEG	slowing,	were	
the most significant markers. These findings are consistent with 
previous studies and the role of theta and alpha rhythms in cog‐
nitive	 performance:	 Klimesch	 (1999)	 observed	 that	 “upper	 alpha	
desynchronization	 correlates	 with	 semantic	memory	 performance	
whereas	 theta	 synchronization	 correlates	 with	 working	 memory	
or episodic memory performance in particular.” The same author 
stated:	“Because	alpha	frequency	varies	to	a	large	extent	as	a	func‐
tion	of	age,	neurological	diseases,	memory	performance,	brain	vol‐
ume,	and	task	demands,	the	use	of	fixed	frequency	bands	does	not	
seem	justified”.	The	current	approach	of	recording	the	EEG	during	a	
memory	task	and	computing	markers	using	individualized	frequency	
bands	corroborate	these	ideas.	Surprisingly,	neither	coherence	nor	
F I G U R E  3  Visualization	of	the	regression	model:	Each	window	shows	the	scatterplot	of	a	standardized	marker	versus	standardized	log‐
transformed	MMSE	scores	(corrected	for	the	remaining	markers)	where	a	black	dot	represents	a	subject,	the	green	line	represents	the	partial	
regression	and	the	light	green	area	its	95%	confidence	band.	The	combined	markers	explain	38.2%	of	MMSE	variation
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
MRI 77.78 52.08 68.06 64.10 66.67
EEG 87.30 68.75 78.57 80.49 79.28
MRI	+	EEG 92.06 75.00 82.86 87.80 84.68
Note.	NPV:	negative	predictive	value;	PPV:	positive	predictive	value.
TA B L E  4  Evaluation	of	MMSE	≥	24	and	
MMSE	<	24	classification	using	magnetic	
resonance	imaging	(MRI)	markers,	
electroencephalography	(EEG)	markers,	
and markers from both modalities
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cMI	–	both	measures	of	functional	coupling	–	were	selected	into	the	
final	set	of	markers.	Especially,	changes	in	EEG	coherence	have	been	
related	to	AD	progression	(Jeong,	2004).	There	are	several	possible	
explanations	for	this	result.	On	the	one	hand,	coherence	and	cMI	are	
clearly	 correlated	with	 other	 EEG	markers	 and	 by	 including	 those	
parts of the functional coupling information is implicitly included in 
our	model.	On	the	other	hand,	our	approach	of	global	markers	might	
not be well‐suited to capture the topographic characteristic of func‐
tional	coupling	markers.	Finally,	the	changes	 in	functional	coupling	
during	early	AD	might	be	too	subtle	to	be	used	as	accurate	marker	
of cognitive decline.
A	limitation	of	this	study	is	the	sole	use	of	MMSE	scores	as	mea‐
sure	 of	 the	 global	 cognitive	 status.	 AD	 typically	 impairs	 cognitive	
complex	domains,	 the	sequence	and	severity	of	 impairment	varies	
from	patient	to	patient,	even	more	so	in	the	earliest	disease	stages.	
Another	well‐described	issue	of	the	MMSE	is	its	susceptibility	to	de‐
mographic	factors	such	as	age	and	education.	In	the	current	study,	
we tried to overcome this limitation by including demographic infor‐
mation	as	covariates.	However,	a	single	MMSE	cutoff	to	distinguish	
stages	of	cognitive	impairment	is	thus	problematic,	and	it	is	import‐
ant to bear in mind the possible resulting bias. By using more elab‐
orate	cognitive	tests	that	are	less	sensitive	to	demographic	factors,	
further research should be undertaken to investigate which markers 
reflect deficits in which cognitive domain.
5  | CONCLUSION
The purpose of this study was a systematic assessment of the use‐
fulness	of	different	MRI	and	EEG	measures	as	symptom‐independ‐
ent	markers	of	the	severity	of	cognitive	deficits	in	early	AD.	Our	
study	has	demonstrated	the	potential	of	a	combined	MRI–EEG	ap‐
proach	by	 separating	 subjects	with	MMSE	≥	24	 from	 those	with	
MMSE	<	24	with	an	accuracy	of	84.7%.	These	results	suggest	that	
the current diagnostic workup might benefit from an inclusion of 
joint	MRI–EEG	markers.	These	markers	may	represent	noninvasive	
and	cost‐effective	means	to	gain	information	on	early	AD	progres‐
sion that could be essential in timely treatment and facilitate ad‐
ditional	 clinical	 research.	 Further	 studies	 in	 larger	 populations	
are	warranted	 to	validate	 the	current	 results.	Longitudinal	 study	
designs are particularly relevant to confirm the evident potential 
of these markers and to estimate their true diagnostic accuracy. 
Finally,	 cross‐modality	 validation	 against	 functional–metabolic	
imaging might further increase the understanding of disease 
progression.
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